Piwil2 expressed in various stages of cervical neoplasia is a potential complementary marker for p16.
Generally, cancers may undergo the developmental stages of benign proliferation, precancer and invasive cancer. Identification of biomarkers that are expressed throughout the developmental stages will facilitate detection, prevention and therapy of cancer. Piwil2, a member of AGO/PIWI family of proteins, has been suggested to be associated with tumor development. Here we reported that piwil2 can be detected by immunohistochemistry (IHC) in various stages of human cervical squamous cell carcinomas and adenocarcinomas. Interestingly, piwil2 was also detected in some metaplastic epithelial cells as well as histologically "normal" appearing tissues adjacent to malignant lesions. While all the premalignant and malignant lesions expressed varying levels of piwil2, p16(INK4a) (p16), a surrogate indicator of high-risk human papillomavirus (HR-HPV) infection, was detected in only 84.62% of the specimens. In Papanicolaou (Pap) test, piwil2 was also detected in atypical glandular cells (AGC), low-grade (LSIL) and high-grade squamous intraepithelial lesions (HSIL), whereas p16 was not always concomitantly detected in the same specimens. The results suggest that piwil2 might play important roles throughout the process of cervical cancer development and have the potential to be used as a complementary marker for p16(INK4a). It is worth further study to improve the sensitivity and specificity of current screening methods for cervical cancers.
He
Gang
G
Chen
Li
L
Ye
Yin
Y
Xiao
Yi
Y
Hua
Keding
K
Jarjoura
David
D
Nakano
Toru
T
Barsky
Sanford H
SH
Shen
Rulong
R
Gao
Jian-Xin
JX
Science. 2007 May 4;316(5825):744-7
17446352
Genomics. 2003 Sep;82(3):323-30
12906857
Int J Clin Exp Pathol. 2010 Mar 20;3(4):328-37
20490325
Cell. 2006 Jun 2;125(5):873-86
16751098
Cell. 2007 Mar 23;128(6):1089-103
17346786
Cancer Detect Prev. 2006;30(5):387-94
17079091
Clin Cancer Res. 2006 Nov 15;12(22):6626-36
17121881
Clin Cancer Res. 2005 Jan 1;11(1):166-72
15671542
Int J Clin Exp Pathol. 2009;2(1):21-33
18830381
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):989-95
16467114
Curr Biol. 2009 Apr 28;19(8):640-4
19345100
Hum Mol Genet. 2006 Jan 15;15(2):201-11
16377660
Cancer. 2005 Dec 25;105(6):457-60
16104044
MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24
17380109
J Cell Mol Med. 2008 Jan-Feb;12(1):67-96
18053092
PLoS One. 2008 Feb 20;3(2):e1652
18286204
PLoS One. 2009;4(2):e4544
19229342
J Immunol. 2003 Jun 15;170(12):5927-35
12794119
Nature. 2006 Jul 13;442(7099):203-7
16751777
Genes Dev. 2006 Jul 1;20(13):1709-14
16766680
Nat Med. 2004 Aug;10(8):789-99
15286780
J Biol Chem. 2009 Mar 6;284(10):6507-19
19114715
Clin Gastroenterol Hepatol. 2004 Jan;2(1):1-8
15017625
Lancet. 2007 Sep 8;370(9590):890-907
17826171
Mol Reprod Dev. 2006 Feb;73(2):173-9
16261612
Genes Dev. 2006 Aug 15;20(16):2214-22
16882972
JAMA. 2002 Apr 24;287(16):2120-9
11966387
N Engl J Med. 1998 Feb 12;338(7):423-8
9459645
Science. 2006 Jul 21;313(5785):363-7
16778019
Am J Pathol. 1998 Dec;153(6):1741-8
9846965
Genes Dev. 2002 Nov 1;16(21):2733-42
12414724
Nature. 2009 Apr 9;458(7239):719-24
19360079
Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):295-301
17301262
Int J Gynecol Pathol. 2009 Jan;28(1):90-7
19047902
Annu Rev Cell Dev Biol. 2009;25:355-76
19575643
Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13415-20
16938833
Nature. 2007 Nov 8;450(7167):304-8
17952056
Cancer Cell Int. 2007 Mar 15;7:2
17362521
Cancer Lett. 1999 Feb 8;136(1):101-8
10211947
PLoS One. 2007 Mar 14;2(3):e293
17356702
Cancer. 2006 Dec 25;108(6):451-61
17078096
Oncogene. 2002 Jun 6;21(25):3988-99
12037681
Development. 2004 Feb;131(4):839-49
14736746
BMC Cancer. 2004 Jul 19;4:37
15257755
Science. 2004 Sep 3;305(5689):1437-41
15284456
Trends Mol Med. 2008 Aug;14(8):323-32
18635398
Cancer Treat Rev. 2009 May;35(3):210-20
19261387
J Cell Physiol. 2000 Mar;182(3):311-22
10653597
Mech Dev. 2001 Oct;108(1-2):121-33
11578866
Genes Dev. 1998 Dec 1;12(23):3715-27
9851978
J Natl Cancer Inst. 2005 Sep 21;97(18):1317-9
16174847
J Natl Cancer Inst. 2005 Sep 21;97(18):1330-8
16174854